A detailed history of Veriti Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Veriti Management LLC holds 12,182 shares of RDY stock, worth $176,395. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,182
Previous 11,404 6.82%
Holding current value
$176,395
Previous $868,000 11.41%
% of portfolio
0.05%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$75.41 - $84.21 $58,668 - $65,515
778 Added 6.82%
12,182 $967,000
Q2 2024

Aug 02, 2024

BUY
$68.26 - $76.19 $52,560 - $58,666
770 Added 7.24%
11,404 $868,000
Q1 2024

Apr 19, 2024

BUY
$67.36 - $77.59 $16,907 - $19,475
251 Added 2.42%
10,634 $780,000
Q4 2023

Feb 05, 2024

BUY
$64.27 - $69.9 $78,795 - $85,697
1,226 Added 13.39%
10,383 $722,000
Q3 2023

Oct 27, 2023

BUY
$61.9 - $72.77 $56,576 - $66,511
914 Added 11.09%
9,157 $612,000
Q2 2023

Jul 13, 2023

SELL
$53.34 - $63.11 $7,307 - $8,646
-137 Reduced 1.63%
8,243 $520,000
Q1 2023

Apr 26, 2023

BUY
$51.63 - $56.93 $60,355 - $66,551
1,169 Added 16.21%
8,380 $477,000
Q4 2022

Jan 20, 2023

BUY
$51.15 - $57.45 $61,482 - $69,054
1,202 Added 20.0%
7,211 $0
Q3 2022

Oct 26, 2022

BUY
$49.9 - $57.32 $28,492 - $32,729
571 Added 10.5%
6,009 $315,000
Q2 2022

Jul 18, 2022

BUY
$49.62 - $58.13 $30,863 - $36,156
622 Added 12.92%
5,438 $301,000
Q1 2022

Apr 11, 2022

BUY
$48.27 - $65.25 $16,604 - $22,446
344 Added 7.69%
4,816 $268,000
Q4 2021

Jan 19, 2022

SELL
$59.5 - $67.25 $5,950 - $6,725
-100 Reduced 2.19%
4,472 $293,000
Q3 2021

Oct 08, 2021

SELL
$60.19 - $75.29 $51,582 - $64,523
-857 Reduced 15.79%
4,572 $298,000
Q2 2021

Jul 13, 2021

BUY
$62.12 - $74.2 $337,249 - $402,831
5,429 New
5,429 $399,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.4B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.